Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Zhang

Showing results (451-460 of 459) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 459 results.
American Journal of Hematology|October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemiaMaximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Nature Communications|July 19, 2020
Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Nature Medicine|August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
Pageof 46

Showing results (451-460 of 459) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 459 results.
American Journal of Hematology|October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemiaMaximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Nature Communications|July 19, 2020
Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Nature Medicine|August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
Pageof 46